title: Recombinant or urinary gonadotrophins - an Australian perspective.
abstract: The Australian experience of gonadotrophin stimulation is a useful example of steps that lead to a country deciding to use recombinant FSH solely.
authors.affiliation: Research Centre for Reproductive Health, Department of Obstetrics and Gynaecology, University of Adelaide, The Queen Elizabeth Hospital, Woodville, SA. Robert.Norman@adelaide.edu.au
authors.forename: R J
authors.initials: RJ
authors.lastname: Norman
authors.forename: S
authors.initials: S
authors.lastname: de Lacey
authors.forename: J X
authors.initials: JX
authors.lastname: Wang
mesh_terms: D001315:Australia; D005260:Female; D005300:Fertility Agents, Female / Q000592:standards / Q000627:therapeutic use*; D005640:Follicle Stimulating Hormone / Q000627:therapeutic use*; D006062:Gonadotropins / Q000235:genetics / Q000627:therapeutic use* / Q000652:urine; D006801:Humans; D007247:Infertility, Female / Q000188:drug therapy*; D010062:Ovulation Induction / Q000379:methods / Q000592:standards*; D011994:Recombinant Proteins / Q000627:therapeutic use
chemical_list: D005300:Fertility Agents, Female; D006062:Gonadotropins; D011994:Recombinant Proteins; D005640:Follicle Stimulating Hormone